Industry News
NHMRC reports on progress to improve clinical trials
The National Health and Medical Research Council (NHMRC), tasked with implementing a range of initiatives designed to make the process of initiating and conducting clinical trials in Australia significantly more efficient and cost effective, has reported on the progress of work under the initiative and advised it will update the information monthly.
[ + ]Hitachi Data Systems awards Intersect Australia
Hitachi Data Systems has presented eResearch support agency Intersect Australia with the APAC Health and Life Sciences Innovation Award, recognising the company's achievements in fostering collaboration, innovation and efficiencies in the medical research sector. [ + ]
ACD and Leica Biosystems co-market RNA in situ hybridisation platform
Leica Biosystems and Advanced Cell Diagnostics are co-marketing ACD's RNAscope LS ISH assays with Leica Biosystems' Bond RX research staining platform. The agreement provides researchers with an integrated and fully automated ISH solution. [ + ]
Abcam establishes direct service for ANZ
Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors, which is expected to improve delivery times and better meet researchers' needs. [ + ]
Miltenyi Biotec acquires gene therapy assets from Lentigen
Global biotechnology company Miltenyi Biotec has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen, a provider of lentiviral technology for cell and gene therapy applications. [ + ]
GE Healthcare appoints BioProcess chief for Asia
GE Healthcare Life Sciences has selected Olivier Loeillot to take on the newly created role of GM Asia commercial for its BioProcess business.
[ + ]National Science Week
This week, Australia celebrates all things science in National Science Week. [ + ]
Bioscience Managers' first fund achieves 24.7% IRR
Bioscience Managers' first fund returned $1.76 per $1 invested, thanks to its portfolio which includes Alchemia (ASX:ACL) Bionomics (ASX:BNO), Acrux (ASX:ACR) and HeartWare (ASX:HIN).
[ + ]Two new national awards
The Australian Academy of Science has announced two new national awards, following a generous donation by immunologist and Corresponding Member (international Fellow) of the academy Professor Sir Marc Feldmann. [ + ]
Tanya Monro appointed chair of the National Youth Science Forum
The new chair of the National Youth Science Forum (NYSF) governing council has been announced as Professor Tanya Monro - an internationally acclaimed physicist who is passionate about improving the community's understanding of the relevance of physics and science in general. [ + ]
Academy announces two new science awards
The Australian Academy of Science has announced two new national awards for early- and mid-career researchers, named after pre-eminent scientists Sir Gustav Nossal and Jacques Miller. [ + ]
Cracking the code for generating stem cells
Observing the generation of stem cells in zebra fish embryos shows that hematopoietic stem cells are generated with the help of 'buddy' cells. [ + ]
Industry leaders propose AIM Incentive to boost innovation
Australian industry leaders have proposed an Australian Innovation & Manufacturing (AIM) Incentive in submissions to the Senate's inquiry into Australia's innovation system. [ + ]
Novogen lines up a double dose of funding
Novogen (ASX:NRT) has won shareholder approval to raise funds to bring drug candidates into clinical trials and support from a FSHD foundation for its regenerative program with Genea Biocells. [ + ]
Perth's Orthocell lists on ASX
Orthocell (ASX:OCC) has listed on the ASX following last month's $8m IPO and started receiving royalty revenue from China for regenerative medicine product Ortho-ACI. [ + ]
